Company intelligence / Profile preview

Rellim Capital Management

Glenview, Illinois, United States

Ownership: Private
Development stage: Other

Overview

Rellim Capital Management is an active boutique/family investment firm that provides bespoke investment solutions to high net worth individuals and families and has made at least one disclosed venture investment in a biotech company (Orbital Therapeutics), but it is not itself a life science/biotech/healthcare company.

Industry: Investors

Partnerships

Invested as a financial investor in Orbital Therapeutics' $270M Series A financing round in April 2023, alongside ARCH Venture Partners, Andreessen Horowitz (a16z Bio + Health), Abu Dhabi Growth Fund, Redmile Group, Exor, Invus, Moore Strategic Ventures, Casdin Capital, Alexandria Venture Investments, Heritage Medical Systems, Newpath Partners, and others.

Beyond the preview

Go deeper on Rellim Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rellim Capital Management.

Explore the full profile